Santé Ventures’ Kevin Lalande on how to drive returns in an era of overvaluation
Last month, the Austin, Texas-based VC announced the close of their third fund, a $250 million fund that exceeded the company's initial $200 million goal.
Orphan drug startups are on a roll: Texas biopharma nabs $14M for rare autism disorder
In yet another example of industry’s growing interest in orphan drugs, a small Texas startup secured an impressive Series A to ramp up its work on a treatment for a rare disease called CTD. Life science investors Sante Ventures and New Enterprise Associates co-led the $14 million Series A for Lumos Pharma, which is repurposing […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Rise Health of Chicago raises $1.5M for primary care support services
Rise Health Inc. has raised $1.5 million in equity for its primary care physician support services, according to a document filed with the Securities and Exchange Commission. Seeking to help ease the burdens of the U.S. primary care shortage, Rise contracts with physicians to provide operational and clinical support services, such as assisting with patient care and data management.